# FDA WARNING_LETTER - SilveryGuy - August 12, 2020

Source: https://www.globalkeysolutions.net/records/warning_letter/silveryguy/b6a70a82-d025-484b-9f8c-4dd2bf619e4d

> FDA WARNING_LETTER for SilveryGuy on August 12, 2020. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: SilveryGuy
- Inspection Date: 2020-08-12
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Summary: On August 14, 2020, the FDA and FTC issued a Warning Letter to Silveryguy.com, an Amazon Associate, for promoting and participating in the sale of "Colloidal Silver" with unproven COVID-19 claims. The FDA reviewed the company's website (www.silveryguy.com) and Facebook page (www.facebook.com/silveryguy/) on August 5 and 12, 2020.

The violations include marketing Colloidal Silver with claims implying it can mitigate, prevent, treat, diagnose, or cure COVID-19. This causes the product to be an unapproved new drug under Section 505(a) of the FD&C Act (21 U.S.C. § 355(a)) and a misbranded drug under Section 502 (21 U.S.C. § 352). Introducing or delivering these products into interstate commerce is prohibited under Sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)), and misbranding a drug held for sale after interstate shipment is prohibited under Section 301(k) (21 U.S.C. § 331(k)).

The letter cites the public health emergency and national emergency declarations related to COVID-19. Sil

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/donald-d-ashley/060f0dda-e6e8-4f9c-97e7-f540d523d902)
- [Associate Director](https://www.globalkeysolutions.net/people/serena-viswanathan/7d1b292d-1f22-42ff-8452-0bc9673b8326)

Company: https://www.globalkeysolutions.net/companies/silveryguy/0337264d-46c5-48e1-8736-2807ff91994c

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c